Elevance Health Price to Sales Ratio 2010-2024 | ELV
Historical PS ratio values for Elevance Health (ELV) over the last 10 years. The current P/S ratio for Elevance Health as of September 16, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Elevance Health P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-09-17 | 543.51 | 0.74 | |
| 2024-06-30 | 540.24 | $730.65 | 0.74 |
| 2024-03-31 | 515.42 | $726.27 | 0.71 |
| 2023-12-31 | 467.21 | $720.41 | 0.65 |
| 2023-09-30 | 430.08 | $705.22 | 0.61 |
| 2023-06-30 | 437.41 | $688.94 | 0.63 |
| 2023-03-31 | 451.25 | $664.01 | 0.68 |
| 2022-12-31 | 501.81 | $643.94 | 0.78 |
| 2022-09-30 | 443.27 | $627.71 | 0.71 |
| 2022-06-30 | 469.70 | $608.43 | 0.77 |
| 2022-03-31 | 476.85 | $586.54 | 0.81 |
| 2021-12-31 | 448.75 | $561.15 | 0.80 |
| 2021-09-30 | 359.89 | $538.07 | 0.67 |
| 2021-06-30 | 367.46 | $515.02 | 0.71 |
| 2021-03-31 | 344.46 | $492.78 | 0.70 |
| 2020-12-31 | 307.09 | $477.82 | 0.64 |
| 2020-09-30 | 256.12 | $457.97 | 0.56 |
| 2020-06-30 | 249.89 | $437.99 | 0.57 |
| 2020-03-31 | 215.03 | $420.98 | 0.51 |
| 2019-12-31 | 285.06 | $399.49 | 0.71 |
| 2019-09-30 | 225.98 | $382.67 | 0.59 |
| 2019-06-30 | 264.76 | $367.68 | 0.72 |
| 2019-03-31 | 268.47 | $356.86 | 0.75 |
| 2018-12-31 | 245.04 | $348.58 | 0.70 |
| 2018-09-30 | 255.70 | $344.80 | 0.74 |
| 2018-06-30 | 221.48 | $341.19 | 0.65 |
| 2018-03-31 | 203.76 | $337.19 | 0.60 |
| 2017-12-31 | 208.00 | $334.74 | 0.62 |
| 2017-09-30 | 174.98 | $331.04 | 0.53 |
| 2017-06-30 | 172.74 | $326.88 | 0.53 |
| 2017-03-31 | 151.33 | $324.14 | 0.47 |
| 2016-12-31 | 131.04 | $316.67 | 0.41 |
| 2016-09-30 | 113.71 | $309.66 | 0.37 |
| 2016-06-30 | 118.57 | $303.75 | 0.39 |
| 2016-03-31 | 124.87 | $296.72 | 0.42 |
| 2015-12-31 | 124.66 | $288.82 | 0.43 |
| 2015-09-30 | 124.57 | $281.24 | 0.44 |
| 2015-06-30 | 145.43 | $272.63 | 0.53 |
| 2015-03-31 | 136.29 | $264.26 | 0.52 |
| 2014-12-31 | 110.44 | $257.35 | 0.43 |
| 2014-09-30 | 104.77 | $249.87 | 0.42 |
| 2014-06-30 | 93.91 | $243.19 | 0.39 |
| 2014-03-31 | 86.52 | $236.95 | 0.37 |
| 2013-12-31 | 79.91 | $233.37 | 0.34 |
| 2013-09-30 | 72.02 | $221.61 | 0.32 |
| 2013-06-30 | 70.19 | $210.67 | 0.33 |
| 2013-03-31 | 56.52 | $198.84 | 0.28 |
| 2012-12-31 | 51.68 | $186.86 | 0.28 |
| 2012-09-30 | 48.96 | $181.64 | 0.27 |
| 2012-06-30 | 53.58 | $176.67 | 0.30 |
| 2012-03-31 | 61.73 | $170.80 | 0.36 |
| 2011-12-31 | 55.16 | $164.60 | 0.34 |
| 2011-09-30 | 54.16 | $157.81 | 0.34 |
| 2011-06-30 | 65.10 | $151.31 | 0.43 |
| 2011-03-31 | 57.48 | $144.88 | 0.40 |
| 2010-12-31 | 46.66 | $139.36 | 0.33 |
| 2010-09-30 | 46.48 | $143.65 | 0.32 |
| 2010-06-30 | 40.16 | $139.77 | 0.29 |
| 2010-03-31 | 52.83 | $137.25 | 0.38 |
| 2009-12-31 | 47.84 | $133.90 | 0.36 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $128.349B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $47.536B | 18.17 |
| ICON (ICLR) | Ireland | $24.384B | 21.91 |
| DiDi Global (DIDIY) | China | $18.907B | 0.00 |
| Avantor (AVTR) | United States | $18.492B | 28.04 |
| Natera (NTRA) | United States | $16.038B | 0.00 |
| Revvity (RVTY) | United States | $15.146B | 26.52 |
| Viatris (VTRS) | United States | $14.095B | 4.29 |
| CochLear (CHEOY) | Australia | $12.834B | 0.00 |
| Solventum (SOLV) | United States | $12.399B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.058B | 33.56 |
| Charles River Laboratories (CRL) | United States | $10.519B | 19.88 |
| Sonic Healthcare (SKHHY) | Australia | $8.839B | 0.00 |
| Doximity (DOCS) | United States | $7.322B | 46.40 |
| HealthEquity (HQY) | United States | $6.833B | 37.08 |
| Bausch + Lomb (BLCO) | Canada | $6.266B | 26.97 |
| PACS (PACS) | United States | $6.244B | 0.00 |
| Organon (OGN) | United States | $5.376B | 5.47 |
| Life Times (LTH) | United States | $4.877B | 40.77 |
| Sotera Health (SHC) | United States | $4.789B | 24.16 |
| Surgery Partners (SGRY) | United States | $4.050B | 44.87 |
| Concentras Parent (CON) | United States | $2.956B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.914B | 109.71 |
| Ardent Health Partners (ARDT) | United States | $2.506B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $2.387B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.202B | 0.00 |
| Progyny (PGNY) | United States | $2.195B | 38.59 |
| Premier (PINC) | United States | $2.080B | 9.35 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.023B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.751B | 8.79 |
| CareDx (CDNA) | United States | $1.568B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.397B | 0.00 |
| Agilon Health (AGL) | United States | $1.350B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.248B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.016B | 0.00 |
| Embecta (EMBC) | United States | $0.950B | 6.33 |
| QDM (QDMI) | Hong Kong, SAR China | $0.933B | 24.43 |
| Pediatrix Medical (MD) | United States | $0.923B | 10.05 |
| InnovAge Holding (INNV) | United States | $0.802B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.537B | 0.00 |
| Sharecare (SHCR) | United States | $0.521B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.492B | 0.00 |
| Enhabit (EHAB) | United States | $0.405B | 35.00 |
| Sonida Senior Living (SNDA) | United States | $0.373B | 0.00 |
| DocGo (DCGO) | United States | $0.372B | 14.00 |
| Biodesix (BDSX) | United States | $0.260B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.258B | 0.00 |
| LifeMD (LFMD) | United States | $0.221B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.204B | 0.00 |
| Beauty Health (SKIN) | United States | $0.185B | 0.00 |
| ModivCare (MODV) | United States | $0.181B | 5.76 |
| MultiPlan (MPLN) | United States | $0.153B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.083B | 20.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.082B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.057B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| OncoCyte (OCX) | United States | $0.042B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.041B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.025B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.020B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| KindlyMD (KDLY) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |